Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials.
Papp, Kim A
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. [electronic resource] - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 01 2018 - 1-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1524-4733
10.1016/j.jval.2017.05.025 doi
Adalimumab--therapeutic use
Adult
Anti-Inflammatory Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Clinical Trials, Phase III as Topic
Etanercept--therapeutic use
Female
Humans
Male
Propensity Score
Psoriasis--drug therapy
Quality of Life
Randomized Controlled Trials as Topic
Severity of Illness Index
Treatment Outcome
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. [electronic resource] - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 01 2018 - 1-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1524-4733
10.1016/j.jval.2017.05.025 doi
Adalimumab--therapeutic use
Adult
Anti-Inflammatory Agents--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Clinical Trials, Phase III as Topic
Etanercept--therapeutic use
Female
Humans
Male
Propensity Score
Psoriasis--drug therapy
Quality of Life
Randomized Controlled Trials as Topic
Severity of Illness Index
Treatment Outcome